New BioResolve SCX mAb columns and consumables simplify and improve mAb characterization and monitoring through holistic approach.

Bio-Rad launches of a range of recombinant monoclonal anti-idiotypic antibodies that inhibit the binding of eculizumab (Soliris) to its target, complement C5 protein.

Porvair Sciences has launched a reinforced base version of its 96-well deep round microplate.

Event for experts from academia and industry, including talks, live demo sessions, and panel discussion.

AbCellera will generate panels of antibodies for up to eight drug targets nominated by Denali using AbCellera’s high-throughput, ultra-deep single-cell immune profiling capabilities.

Eppendorf Xplorer plus can now tackle entire columns and rows of a 384-well plate in one single step.

Lonza has further expanded its hepatocytes portfolio characterization with the addition of Verified for Spheroids™ Human Hepatocytes, which are pre-screened for their ability to promote rapid spheroid formation in cell culture.

New antibody purification robots support further company growth.

World's first antibody drug activity analysis column.

Porvair Sciences reports on its involvement in a new £2.6 million project.